stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. COEP
    stockgist
    HomeTop MoversCompaniesConcepts
    COEP logo

    Coeptis Therapeutics Holdings, Inc.

    COEP
    NASDAQ
    Healthcare
    Biotechnology
    Wexford, PA, US5 employeescoeptispharma.com
    $11.94
    +0.66(5.85%)

    Mkt Cap $42M

    $7.05
    $18.80

    52-Week Range

    At a Glance

    AI-generated

    Coeptis Therapeutics Holdings, Inc.

    Revenue breakdown: Advertising Campaigns (91.7%), Webinar Services (8.3%).

    8-K
    Coeptis Therapeutics Holdings, Inc. implemented an option repricing/exchange program for officers and directors, converting certain out-of-the-money options to restricted stock and accelerating the vesting of all options. The company also regained compliance with Nasdaq listing rules after previously failing to hold a required annual meeting.

    $42M

    Market Cap

    $1M

    Revenue

    -$10M

    Net Income

    Employees5
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Advertising Campaigns91.7%($1M)
    Webinar Services8.3%($112.5K)
    Activity

    What Changed Recently

    Management Change
    Feb 11, 2026

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February 1

    Delisting
    Jan 15, 2026

    Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 12, 2026, Coeptis Therapeutics Holdings, Inc. (t

    Shareholder Vote
    Feb 3, 2026

    Submission of Matters to a Vote of Security Holders On January 30, 2026, Coeptis Therapeutics Holdings, Inc. (the “Company”) held an Annual and Special Meeting

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    IPSCCentury Therapeutics, Inc...$2.15-2.05%$186M-21.4
    EQEquillium, Inc.$1.97-3.43%$70M-3.0
    KPTIKaryopharm Therapeutics I...$5.88+1.03%$50M-0.6
    OSTXOS Therapies Incorporated$1.37+0.74%$48M—
    TELOTelomir Pharmaceuticals, ...$1.27-3.79%$44M-4.2
    NRXPNRx Pharmaceuticals, Inc.$2.20+1.85%$38M-1.0
    SNTISenti Biosciences, Inc.$0.87+3.56%$23M-0.5
    CUECue Biopharma, Inc.$0.18-11.20%$14M-1.1
    Analyst View
    Company Profile
    CIK0001759186
    ISINUS19207A2078
    CUSIP19207C104
    Phone724 934 6467
    Address105 Bradford Road, Wexford, PA, 15090, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice